Article
![Medication Medication](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02208036.jpg)
Off-label medications for addictive disorders
- Author:
- Tyler Vanderhoof, MD
- John J. Reitz, MD
- Yi-lang Tang, MD, PhD
Off-label agents may help treat certain substance use disorders and gambling.
Article
![Hands reaching out Hands reaching out](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02202020.jpg)
Extended-release injectable naltrexone for opioid use disorder
- Author:
- Ashmeer Ogbuchi, MD
- Karen Drexler, MD
- Rachel Gluck, MD
- Karen Hochman, MD
- Yi-lang Tang, MD, PhD
We appreciate the important review by Gluck et al (“Managing patients with comorbid opioid and alcohol use disorders,” Current Psychiatry ,...
Article
![Hands reaching out Hands reaching out](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02202020.jpg)
Managing patients with comorbid opioid and alcohol use disorders
- Author:
- Rachel Gluck, MD
- Karen Hochman, MD
- Yi-lang Tang, MD, PhD
Consider the type and severity of withdrawal symptoms, patients’ goals, and other factors.
Article
![Lab monitoring Lab monitoring](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02109012.jpg)
Laboratory monitoring for patients on buprenorphine: 10 questions
- Author:
- Charlotte Van Hale, MD
- Rachel Gluck, MD
- Yi-lang Tang, MD, PhD
How to best use laboratory testing for patients with opioid use disorder.
Article
![Man smoking Man smoking](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Measuring cotinine to monitor tobacco use and smoking cessation
- Author:
- Kimberly R. Stubbs, MD
- Christopher R. Smith, MD
- Yi-lang Tang, MD, PhD
For certain patients, cotinine screening may be a valuable addition to their treatment.